UB
ADMA icon

UMB Bank’s ADMA Biologics ADMA Stock Holding History

UMB Bank’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.2K Sell
577
-569
-50% -$8.98K ﹤0.01% 2031
2025
Q4 		$20.9K Buy
1,146
+239
+26% +$4.03K ﹤0.01% 1546
2025
Q3 		$13.3K Buy
907
+151
+20% +$2.59K ﹤0.01% 1571
2025
Q2 		$13.8K Buy
756
+89
+13% +$1.81K ﹤0.01% 1496
2025
Q1 		$13.2K Buy
667
+279
+72% +$4.83K ﹤0.01% 1453
2024
Q4 		$6.65K Sell
388
-93
-19% -$1.75K ﹤0.01% 1608
2024
Q3 		$9.62K Buy
+481
New +$7.48K ﹤0.01% 1502

Other funds holding ADMA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

UMB Bank's ADMA Position: Q1 2026 in Review

UMB Bank reduced its ADMA Biologics (ADMA) stake by 50% in Q1 2026, selling an estimated $8.98K and leaving 577 shares worth $5.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2031.

UMB Bank first reported a position in ADMA in Q3 2024 and has held it in 7 quarters since. The position peaked at $20.9K in Q4 2025. 356 funds tracked by Wall St. Rank hold ADMA as of Q1 2026.

  • UMB Bank held 577 shares of ADMA Biologics worth $5.2K as of Q1 2026.
  • UMB Bank sold 569 ADMA Biologics shares in Q1 2026, an estimated $8.98K.
  • ADMA Biologics made up ﹤0.01% of UMB Bank's portfolio in Q1 2026, its #2031 holding.
  • UMB Bank first reported a position in ADMA Biologics in Q3 2024 and has held it in 7 quarters since.
  • UMB Bank's ADMA Biologics position peaked at $20.9K in Q4 2025.
  • 356 funds tracked by Wall St. Rank held ADMA Biologics as of Q1 2026.

Based on UMB Bank's 13F filing for Q1 2026, filed 11 May 2026.